A Rare EGFR–SEPT14 Fusion in a Patient with Colorectal Adenocarcinoma Responding to Erlotinib

Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. Growing evidence supports gene fusions as good candidates for molecularly targeted therapy in CRC. Here we describe a case of a 63‐year‐old man who had a radical right hemicolectomy procedure 24 months ago. Pathological d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Li, Yong, Zhang, Hai‐Bo, Chen, Xian, Yang, Xiaobing, Ye, Yongsong, Bekaii‐Saab, Tanios, Zheng, Yaojie, Zhang, Yihong
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Precision Medicine Clinic: Molecular Tumor Board
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066703/
https://ncbi.nlm.nih.gov/pubmed/32162810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0405
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars